Skip to content

Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea

Jean-Michel Molina at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Changes in viral suppression over time reveal disparities in HIV care in the United States

Nicole Crepaz at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Dual antiretroviral regimen maintains durable HIV suppression after switch

Josep Llibre at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Infants treated within days of birth can clear HIV reservoir rapidly

Louise Kuhn at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Treatment-as-prevention study sees substantial levels of transmitted drug resistance in participants, but no impact on treatment

Anne Derache at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Point-of-care test improves infant HIV diagnosis rate, treatment starts and retention in care

Ilesh Jani at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment

Paul Sax at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

A benign circle: how a combination of factors has reduced HIV infections in one of the hardest-hit parts of Africa

Mary Grabowski at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Men from Latin America and central Europe now outnumber sub-Saharan Africans in HIV diagnoses in European migrants